Aromatic gum from Boswellia carteri (olibanum oleogum) has long been used in Egyptian traditional medicine. Cyclooxygenase-1 (COX-1) enzyme inhibitory assay guided purification of the extracts of this resin resulted in five bioactive compounds, 3α-O-acetyl-8,24-dien-tirucallic acid (1), verticilla-4(20),7,11-triene (2), cembrene A (3), incensole acetate (4), and incensole (5). The pure isolates were investigated for their inhibitory effects on COX-1 and -2 enzymes and human tumor cell lines Hep-G2, MCF-7 and RAW 264.7. Compounds 1−5 inhibited COX-2 enzyme by 39.0, 32.7, 60.0, 46.3, and 49.8%, respectively. Furthermore, compound 2 showed an inhibitory concentration of 50% (IC 50 ) at 9 µg/mL against Hep-G2 tumor cell line. This is the first report of COX-1 and -2 enzyme and tumor cell proliferation inhibitory effects of compounds 1 and 2.
Olibanum, also called frankincense, is a well-known natural aromatic oleogum resin produced from trees of the genus Boswellia (Burseraceae). It is native to North Africa, the Arabian Peninsula and India [1a] . B. carteri Birdwood resin has been extensively studied for its chemical composition [1b-1e] . However, little has been done to establish any link between its constituents and its phytoceutical properties, especially anti-inflammatory and anticancer activities. In this investigation, the anti-inflammatory activity of B. carteri resin and its terpenoid isolates were evaluated for cyclooxygenase (COX-1 and COX-2) enzyme inhibitory activity. Furthermore, the anti-proliferative effect of the isolates was assessed on human hepatocarcinoma (HepG2), human breast adenocarcinoma (MCF-7) and raw murine macrophage (RAW 264.7) cell lines using MTT cell viability assay.
Methanolic and EtOAC extracts of B. carteri resin showed an identical TLC profile and hence were pooled. This combined extract at 100µg/mL concentration inhibited COX-1 enzyme by 67.9%. Therefore, it was further purified to afford 3α-O-acetyl-8,24-dien-tirucallic acid (1), verticilla-4(20),7,11-triene (2), cembrene A (3), incensole acetate (4), and incensole (5) . The COX-1 and COX-2 inhibitory activities of the isolated compounds were examined and it was found that at 25 µg/mL, compounds 1−5 inhibited COX-1 by 25, 36, 37, 39 and 34%, and COX-2 enzyme by 39, 33, 60, 46 and 50%, respectively ( Figure 1 ). Compounds 3−5 showed similar COX-2 enzyme inhibition as ibuprofen and naproxen, used in this assay as positive controls. Amongst them, compound 3 showed the highest inhibition of COX-2 enzyme by 60%, higher than aspirin, ibuprofen and naproxen, the OTC NSAIDs. Our results are in agreement with the reported COX-1 and -2 enzyme inhibitory activities of cembrenoids, incensole and incensole acetate [1b,1f, 4,2a,2b] .
Chemotherapy is one of the commonly used therapeutic approaches for the treatment of cancer, which includes the use of anticancer drugs obtained from natural and synthetic sources [2c]. The significant COX-2 inhibitory activity of the isolates from B. carteri prompted us to evaluate its antiproliferative effect against HepG2, MCF-7 and RAW 264.7 tumor cell lines. Compounds 1−5 showed strong inhibition of cell growth of HepG2 cells, with IC 50 values (concentration of compounds caused 50% inhibition) of 63.8, 9.0, 68.8, 30.8 and 28.7 µg/mL, respectively, 1−4 against MCF-7 and RAW 264.7 cell lines between 100−300 µg/mL and no activity for 5. Compounds 4 and 5 were reported to exhibit strong cytotoxic activity against human neuroblastoma cell lines IMR-32, NB-39 and SK-N-SH as well [2d]. Several studies suggested that COX inhibitory compounds are effective in the prevention and treatment of several types of cancer [2e]. Our results also correlate the role of COX-2 enzyme in carcinogenesis. Among the olibanum isolates, compound 2 revealed the highest cytotoxic effect against HepG2 cell line and further confirmed that inhibition of COX enzymes could reduce the incidence of tumorigenesis [2f] .The results presented here support the anecdotal use of olibanum gum in traditional medicine.
Experimental
General: Aspirin, naproxen and ibuprofen were purchased from Sigma-Aldrich Chemical Company. The nonsteroidal antiinflammatory drug Celeberex® was a physician's professional sample provided by Dr Subhash Gupta, Sparrow Pain Center, Sparrow Hospital, Lansing, Michigan. COX-1 and -2 enzymes were prepared in our laboratory [2a,3] . COX assays were performed as earlier [3,4a] . 
Extraction and purification:
The pulverized resin of Boswellia carteri (100 g) was stirred in boiling water (500 mL) for 30 min, cooled to room temperature and centrifuged. The supernatant was lyophilized to yield dried water extract (5 g). The residue was extracted with methanol (150 mL x 3) for 12 h, centrifuged and the supernatants evaporated under vacuum to obtain methanolic extract (60 g). The residue from the methanolic extraction was further extracted with ethyl acetate (150 mL x 3) for 12 h and evaporated under vacuum to yield ethyl acetate extract (25 g). The aqueous extract mostly contained insoluble material and possibly cellulosic and inorganic materials. It was kept aside since it was sparingly soluble in water and other organic solvents. Both MeOH and EtOAc extracts showed similar TLC and bioassay profiles and therefore were combined for purification. An aliquot of the combined extract (23.5 g) was dissolved in 70 mL n-hexane and kept in the refrigerator overnight. The n-hexane soluble portion was subjected to vacuum liquid chromatography (VLC) and eluted with n-hexane (500 mL), n-hexane/EtOAc (6:1, 500 mL), n-hexane/EtOAc (1:1, 500 mL), and EtOAc (500 mL) to yield 5 fractions, A (0.37 g), B (7.54 g), C (4.81 g), D (6.76 g), and E (2.3 g) based on the TLC profile. Fraction A yielded pure verticilla-4(20),7,11-triene (2) (370 mg) [1d,e,4b] . Fraction B (3.02 g), fractionated by medium-pressure liquid chromatography (MPLC) with n-hexane/EtOAc (gradient, 15:1, 10:1, 5:1, 3:1, then 1:1) yielded 7 fractions B1 (27.9 mg), BII (806.9 mg), BIII (172.6 mg), BIV (80.9 mg), BV (964.6 mg), BVI (380 mg), and BVII (610 mg). Fraction BI was pure cembrene A (3) (27.9 mg) [1d]. Fraction BVI was crystallized from CHCl 3 /MeOH (1:1) to yield 3α-O-acetyl-8,24-dien-tirucallic acid (1) (40 mg) [5] . The purification of fraction BII (780 mg) by silica gel MPLC, eluted with n-hexane/EtOAC (15:1), afforded incensole acetate (4) (87.7 mg) [4b,6] . Fraction BV (100 mg) was purified further by silica gel preparative TLC using n-hexane/CHCl 3 (1:1, v/v) to obtain incensole (5) (49.1 mg) [4b,6] .
Cyclooxygenase inhibitory assay:
The COX-1 and -2 enzyme antiinflammatory assays were carried out according to our previously published procedures [3, 4] .
Antiproliferative assay: Human hepatocarcinoma (HepG2), human breast adenocarcinoma (MCF-7) and raw murine macrophage (RAW 264.7) cell lines used in the assay were purchased from ATCC, USA. Cells were cultured in DMEM (Dulbecco's Modified Eagle's Medium) for HepG2 and MCF-7 and RPMI-1640 media for RAW 264.7 and assayed according to the published method [3] . Cytotoxicity of isolates 1-5 was measured at concentrations of 12.5−100 µg⁄mL. Assay was repeated 4 times for each concentration and the average was calculated. Cytotoxicity was expressed as the concentration of compounds (µg/mL) inhibiting cell growth by 50% (IC 50 ).
